Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Monsoon
Raksha Bandhan
NV Ramana
Coronavirus India
Coronavirus Cases In India
75 years of Independence
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / COVAXIN for children aged 2-18 by September, says AIIMS chief
India

COVAXIN for children aged 2-18 by September, says AIIMS chief

COVAXIN for children aged 2-18 by September, says AIIMS chief
Written by Sagar
Jun 23, 2021, 10:43 am 2 min read
COVAXIN for children aged 2-18 by September, says AIIMS chief
A coronavirus vaccine for children in India could by ready by September, the chief of AIIMS said.

India's first coronavirus vaccine for children could be ready by September, said Dr. Randeep Guleria, the chief of Delhi's All India Institute of Medical Sciences (AIIMS). Data from COVAXIN's trials on children will be available in September and a regulatory approval is expected that same month, Dr. Guleria told India Today in an interview. COVAXIN is India's only fully indigenous COVID-19 jab so far.

Quote
This is what Dr. Guleria said

"COVAXIN's data for children after completion of the Phase 2/3 trials will be available by September and the approval is expected the same month," Dr. Guleria said in the interview published last night.

Details
COVAXIN clinical trials on children are currently underway

AIIMS-Delhi had this month started screening children for the clinical trials of COVAXIN. A week before that, AIIMS-Patna had begun this jab's clinical trials on children. COVAXIN's Phase 2/3 trials would be conducted on 525 volunteers at several sites. Bharat Biotech, which developed this vaccine, had last month obtained permission from the Drugs Controller General of India to carry out its trials on children.

Other candidates
Zydus Cadila, Pfizer could provide more options to India

Meanwhile, the Ahmedabad-based firm Zydus Cadila is also testing its COVID-19 vaccine candidate on children aged 12-18. Data from its trials will help authorities in determining if its vaccine could be used in children. That apart, India is expected to soon grant regulatory approval to Pfizer, whose COVID-19 vaccine is already approved for children in several countries, implying that could potentially be another option.

Concerns
Will the third wave be more dangerous for children?

Until recently, it was being widely believed that a new wave of COVID-19 infections would affect children harder. However, experts have said there is no data available yet to prove that theory. Citing a recent seroprevalence study by AIIMS and the WHO, the Indian government has made it clear that the level of antibodies has been found quite similar among both adults and children.

Situation
India's coronavirus situation

India had faced the world's worst coronavirus outbreak earlier this year, witnessing lakhs of cases and thousands of fatalities daily. Daily cases in India had peaked at 4,14,000 in early May. The situation has since improved. In the past 24 hours, the country reported 50,848 new cases and 1,358 deaths. Nearly 18% of the Indian population has been partially vaccinated against the coronavirus.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Sagar
Sagar
Twitter
Sagar covers national news for NewsBytes. He has previously worked as an editorial intern at NDTV. Over the course of his near three-year career, Sagar has gained experience in news writing, copy editing, and video production. He holds a Bachelor's degree in Journalism and Mass Communication from the University of Delhi.
Latest
India
Randeep Guleria
Coronavirus
COVID-19
COVAXIN
Latest
India to relocate Rohingya refugees to EWS flats in Delhi
India to relocate Rohingya refugees to EWS flats in Delhi India
National Thrift Shop Day: Here's why thrifting is sustainable
National Thrift Shop Day: Here's why thrifting is sustainable Lifestyle
ED names Jacqueline as accused in Rs. 200cr extortion case
ED names Jacqueline as accused in Rs. 200cr extortion case Entertainment
WhatsApp introduces new desktop app for Windows: How to use
WhatsApp introduces new desktop app for Windows: How to use Technology
Maharashtra: With no roads to hospital, tribal woman loses newborns
Maharashtra: With no roads to hospital, tribal woman loses newborns Mumbai
India
Here's how you can protect yourself from monkeypox
Here's how you can protect yourself from monkeypox Lifestyle
What to do with the Indian flag after Independence Day
What to do with the Indian flag after Independence Day India
Will oppose distortion of history: Congress after BJP questions Nehru
Will oppose distortion of history: Congress after BJP questions Nehru India
India@75: National Flag unfurled in space by Space Kidz India
India@75: National Flag unfurled in space by Space Kidz India India
How has Indian Rupee performed against US Dollar since Independence?
How has Indian Rupee performed against US Dollar since Independence? Business
More News
Randeep Guleria
AIIMS Delhi nurses' union launches indefinite strike today: Details here
AIIMS Delhi nurses' union launches indefinite strike today: Details here India
COVID-19 vaccines for children likely by September, says AIIMS chief
COVID-19 vaccines for children likely by September, says AIIMS chief India
When can your kid return to school? AIIMS chief answers
When can your kid return to school? AIIMS chief answers India
Need more data to approve mixed vaccines, says AIIMS chief
Need more data to approve mixed vaccines, says AIIMS chief India
'Report not final,' says AIIMS chief on Delhi oxygen controversy
'Report not final,' says AIIMS chief on Delhi oxygen controversy India
More News
Coronavirus
Delhi makes mask mandatory, Rs. 500 fine imposed on violators
Delhi makes mask mandatory, Rs. 500 fine imposed on violators Delhi
All about the new Langya virus that has hit China
All about the new Langya virus that has hit China World
New COVID-19 sub-variant BA.2.75 detected in India: WHO
New COVID-19 sub-variant BA.2.75 detected in India: WHO India
How long does immunity last after COVID-19?
How long does immunity last after COVID-19? Technology
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming
#NewsBytesExplainer: Why experts believe 4th COVID-19 wave is not coming India
More News
COVID-19
Bharat Biotech completes third-phase of intranasal COVID-19 vaccine trials
Bharat Biotech completes third-phase of intranasal COVID-19 vaccine trials India
Congress chief Sonia Gandhi tests COVID-19 positive again
Congress chief Sonia Gandhi tests COVID-19 positive again Politics
With 2,726, Delhi reports highest COVID-19 cases in 7 months
With 2,726, Delhi reports highest COVID-19 cases in 7 months India
Meet Qamar Mohsin Shaikh, PM Modi's rakhi sister from Pakistan
Meet Qamar Mohsin Shaikh, PM Modi's rakhi sister from Pakistan India
How changes in airfare rules from August-end will affect prices
How changes in airfare rules from August-end will affect prices Business
More News
COVAXIN
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension India
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years
DCGI clears COVAXIN, Corbevax for children aged 6-12, 5-12 years India
COVAXIN likely to get approval for children above 2yrs: Report
COVAXIN likely to get approval for children above 2yrs: Report India
COVID-19: China fighting worst outbreak, UK sets new high
COVID-19: China fighting worst outbreak, UK sets new high World
COVAXIN, Covishield will now be available in hospitals and clinics
COVAXIN, Covishield will now be available in hospitals and clinics India
More News
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022